Signum Surgical wins €3.6 million grants for colorectal disease therapy
Signum Surgical, which is developing minimally invasive technologies to treat colorectal diseases, has secured two grants totalling €3.6 million: €2.3 million from the EU Horizon 2020 SME Instrument, and €1.3 million from Ireland’s Disruptive Technologies Innovation Fund.